WAGNER CHARLES F JR 4

What Happened

• Charles F. Wagner Jr., listed as EVP, CO & FO of Vertex Pharmaceuticals (VRTX), disposed of 4,565 shares on 2026-02-13. The shares were reported at $487.76 each, for a total value of $2,226,624. The filing lists the transaction code F — a payment of exercise price or tax liability — indicating these shares were surrendered/withheld to cover taxes related to an equity award or option exercise.

Key Details

• Transaction date: 2026-02-13
• Price per share: $487.76
• Shares disposed: 4,565; total value: $2,226,624
• Transaction code: F (payment of exercise price or tax liability / share withholding)
• Shares owned after the transaction: not stated in the provided filing excerpt
• Filing date / accession: filed 2026-02-18 (see official Form 4 for timeliness and any footnotes)

Context

• This was a tax-withholding disposition (common after option exercises or vesting), not an open-market sale intended to take a market position; such withholding transactions are often procedural. The filing does not indicate a new purchase or broader change in ownership; retail investors should treat this as routine unless further insider purchases/sales are disclosed.